MEIJI
LIVE

Serial Number

90054408

Owner

MEIJI HOLDINGS CO., LTD

Attorney

Karen Lim

Filing Date

Jul 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MEIJI Trademark

Serial Number: 90054408 • Registration: 6481882

MEIJI is a trademark filed by MEIJI HOLDINGS CO., LTD on July 15, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MEIJI HOLDINGS CO., LTD (15 trademarks)

4-16, KYOBASHI 2-CHOME
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

July 15, 2020

Registration Date

September 14, 2021

Published for Opposition

April 13, 2021

Goods & Services

Pharmaceutical and veterinary preparations all for the treatment of diseases and disorders of the central nervous system, peripheral nervous system, sensory organs, respiratory organs and digestive organs, cardiovascular system and metabolism; pharmaceutical preparations for the treatment of skin diseases; allergy medication; antiseptics; anthelmintics; pharmaceutical preparations for the treatment of infectious diseases; veterinary preparations, namely, pain relief medication; veterinary preparations for treatment of intestinal bacteria; sanitary preparations for medical use; antibiotic preparations; vitamin preparations; amino acid preparations for medical or veterinary purposes; amino acid preparations for nutritional purposes; pharmaceutical preparations for the treatment of osteoarthritis and joint diseases; medical preparations, namely, intra-articular injectable preparations based on hyaluronic acid for the treatment of osteoarthritis; medical hyaluronic acid in the form of pre-filled syringes; prepackaged injectable sodium hyaluronate solutions for medical use; fungicides; powdered milk for babies; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; dietary supplements for medical purposes; nutritional supplements for medical use, dietary supplemental drinks containing collagen and/or amino acids; dietary supplements, other than for medical use, namely, dietary supplements containing proteins, amino acid, lipids, carbohydrate, dietary fiber, vitamins, minerals or collagen in the form of granules, powder, jelly, liquid, gels, pastes

Testing, inspection or research of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 9, 2021 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 9, 2021 AITU
NOTICE OF ALLOWANCE CANCELLED
Jul 28, 2021 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 28, 2021 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Mar 10, 2021 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 5, 2021 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2021 TROA
DATA MODIFICATION COMPLETED
Oct 21, 2020 DMCC
ASSIGNED TO LIE
Oct 21, 2020 ALIE
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 15, 2020 GPRN
PRIORITY ACTION E-MAILED
Oct 15, 2020 GPRA
PRIORITY ACTION WRITTEN
Oct 15, 2020 CPRA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 30, 2020 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 30, 2020 PARI
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 25, 2020 GPRN
PRIORITY ACTION E-MAILED
Sep 25, 2020 GPRA
PRIORITY ACTION WRITTEN
Sep 25, 2020 CPRA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 25, 2020 GPRN
PRIORITY ACTION E-MAILED
Sep 25, 2020 GPRA
PRIORITY ACTION WRITTEN
Sep 25, 2020 CPRA
ASSIGNED TO EXAMINER
Sep 24, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2020 NWOS
NEW APPLICATION ENTERED
Jul 18, 2020 NWAP